However, as summarized above, conventional strategies, such as enhancing the immune system to recognize the cancer cells, enhancing cancer cell apoptosis, and inducing anti-angiogenesis effects via regulation of the VEGF signaling pathway, are the major designs used in these cancer gene therapy clinical trials. Here, VEGFA is linked to cancer.